论文信息 - Dinucleotide repeat polymorphisms within the Flt-1 gene in minimal change nephropathy.

Dinucleotide repeat polymorphisms within the Flt-1 gene in minimal change nephropathy.

Dysregulation of Flt-1, a major receptor for vascular permeability factor (VPF), may provide a mechanism for the development of proteinuria in minimal change nephropathy (MCN). The gene for Flt-1 has a polymorphic dinucleotide repeat. We have demonstrated an 88% predominance of one allele and an 80% rate of homozygosity for this polymorphism with no association with MCN.

[1] G. Breier,et al. Vascular Endothelial Growth Factor Induces Endothelial Fenestrations In Vitro , 1998, The Journal of cell biology.

[2] C. Aghajanian,et al. Posttranscriptional regulation of protein expression in human epithelial carcinoma cells by adenine-uridine-rich elements in the 3'-untranslated region of tumor necrosis factor-alpha messenger RNA. , 1997, Cancer research.

[3] H. Gröne,et al. Expression of vascular endothelial growth factor in renal vascular disease and renal allografts , 1995, The Journal of pathology.

[4] Yusuke Nakamura,et al. Dinucleotide repeat polymorphism in the 3' non-coding region of the FLTI gene. , 1993, Human molecular genetics.

[5] E. Manseau,et al. Vascular permeability factor mRNA and protein expression in human kidney. , 1992, Kidney international.

[6] D. S. Rath,et al. Dinucleotide repeat polymorphism at the human fms-related tyrosine kinase gene (FLT1). , 1991, Nucleic acids research.

[7] M. Shibuya,et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. , 1990, Oncogene.

[8] R. Vaughan,et al. Genes encoding the beta-chains of HLA-DR7 and HLA-DQw2 define major susceptibility determinants for idiopathic nephrotic syndrome. , 1990, Clinical science.

[9] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. , 1997, EXS.